The eye can be imaged down_to_the molecular level.
From Dr Schwarz comments in the historic first patient video.
Safety is a huge deal. People will elect this procedure just so they don't have to wear glasses. Same as cosmetic surgery and hair transplants.
The thing holding the company back is the 250 million market cap. This is a very respectable valuation for an experimental biotech.
If it takes off, were talking billions very quickly. We're already a quarter billion dollar company, this is a reflection of confidence shown by the market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.